Epidemic Outbreak of Respiratory Syncytial Virus Infection After the end of the Zero‐COVID‐19 Policy in China: Molecular Characterization and Disease Severity Associated With a Novel RSV‐B Clade
Journal of Medical Virology,
Journal Year:
2025,
Volume and Issue:
97(4)
Published: April 1, 2025
ABSTRACT
The
resurgence
of
respiratory
syncytial
virus
(RSV)
has
become
a
major
concern
recently.
This
study
aimed
to
describe
the
temporal
dynamics,
genotype
variability
and
disease
severity
RSV
infection
after
end
Zero‐COVID‐19
policy
in
Beijing,
China.
A
total
905
patients
were
positive
for
at
National
Center
Respiratory
Medicine
Beijing
from
November
2019
April
2024.
Of
these,
238
samples
different
successfully
sequenced,
96
which
identified
as
RSV‐A
142
RSV‐B.
Phylogenetic
analyses
performed
investigate
genetic
diversity.
first
surge
was
quite
intense
occurred
out
season,
mainly
affecting
children.
subsequent
outbreak
had
significant
impact
among
adults.
cases
caused
by
various
clades
new
clade
B.D.E.1
main
cause
epidemic
Pneumonia
immunocompromised
hosts
more
common
compared
other
clades.
Accumulation
substitutions
could
confer
fitness
advantage
vivo.
However,
there
no
statistical
difference
clinical
outcomes
between
infected
those
addressed
timing
trends
infections,
focusing
on
outbreaks,
molecular
characterization,
associated
with
novel
B.D.E.1.
effective
prevention
strategy
infections
childhood,
immunosuppressed
adults
elderly
might
be
warranted.
Language: Английский
Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022
Mariana Haeberer,
No information about this author
Martin Mengel,
No information about this author
Rong Fan
No information about this author
et al.
Infectious Diseases and Therapy,
Journal Year:
2024,
Volume and Issue:
13(11), P. 2395 - 2413
Published: Oct. 12, 2024
We
aimed
to
describe
the
risk
profile
of
RSV
infections
among
children
aged
≤
24
months
in
Valladolid
from
January
2010
August
2022
and
compare
them
with
influenza
COVID-19
controls.
Language: Английский